Browse Data and Analysis

There have been no major changes to Malaysia's biotechnology regulations in the past year. The country continues to review its Biosafety Act, including how it will regulate gene edited products in the future. Malaysia currently has 61 genetically engineered (GE) products approved for import.

The revision of the Malaysia’s Biosafety Act 2007 and Biosecurity Regulations are on-going, with no anticipated timeframe for publication. In addition, the Department of Biosafety Malaysia conducted a public consultation on Low-Level Presence (LLP)...

Malaysia’s Biosafety Act 2007 and Biosecurity Regulations are currently under review by the Department of Biosafety. As of September 2022, 57 genetically engineered (GE) products have been approved for import, an increase of 14 percent from 2021.

With international funding to develop and implement biosafety regulatory systems drying up in 2019, Caribbean biosafety regulatory efforts remain in idle mode. The region is seeking further funding from the United Nations Environmental Program/Global...

The COVID 19 pandemic in Malaysia saw most government agencies operating at minimum staffing with most working from home throughout 2020 and 2021. This has severely impacted the number of GE events approved by the National Biosafety Board (NBB).

Biosafety regulatory efforts in the Caribbean remain stalled, and it is yet to be seen whether countries can regain the will and secure the international financing required to fully implement their National Biosafety Frameworks in a harmonized manner.

Malaysia currently does not have any domestic production of plant biotechnology.

Many Caribbean Community (CARICOM) Member States have undertaken efforts to comply with their obligations under the Cartagena Protocol on Biosafety (CPB) to the Convention on Biological Diversity....

Malaysia currently does not have any domestic production of plant biotechnology.

Many Caribbean Community (CARICOM) Member States have engaged in efforts to comply with their obligations under the Cartagena Protocol on Biosafety (CPB) to the Convention on Biological Diversity....

Malaysia currently does not have any domestic production of plant biotechnology.

Biotech regulations have been virtually non-existent in the Caribbean. However, that may change in the years ahead....